Corrigendum: NDRG1 Inhibition Sensitizes Osteosarcoma Cells to Combretastatin A-4 Through Targeting Autophagy
Wang, Hongsheng,Li, Wen,Xu, Jing,Zhang, Tao,Zuo, Dongqing,Zhou, Zifei,Lin, Binhui,Wang, Gangyang,Wang, Zhuoying,Sun, Wei,Sun, Mengxiong,Chang, Shimin,Cai, Zhengdong,Hua, Yingqi
DOI: https://doi.org/10.1038/cddis.2017.558
2017-01-01
Cell Death and Disease
Abstract:Correction to: Cell Death and Disease (2017) 8 (9):e3048. doi: 10.1038/cddis.2017.438; published online 14 September 2017 Since the publication of this paper, the authors have noted that there was an error in Figure 1d, in that, the GAPDH for combination treatment with CA-4 and CQ in SJSA cells by mistake duplicated for CQ alone treatment (Figure 3e).